4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-011921
Chief Medical Officer acquired 10,000 shares (option exercise)
- Chief Medical Officer acquired 32,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pang Phillip · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-16 | Exercise or conversion : show line 1 in the form | +10,000 | $0.86 | $8,550 | 77,277 | D |
| 2021-02-16 | Grant or award : show line 2 in the form | +32,000 | 109,277 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-16 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −10,000 | 33,833 | D |
| 2021-02-16 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +64,000 | 64,000 | D |
Loading xslF345X03/doc4.xml…